Rocket, a pharmaceutical company, is trading on the Nasdaq stock exchange. A legal filing disclosed a stock sale involving the company's COO, Christopher James Stevens.
1 report, 1 independent
Updated Aug 15
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Rocket, a pharmaceutical company, is trading on the Nasdaq stock exchange. A legal filing disclosed a stock sale involving the company's COO, Christopher James Stevens.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
Related events
- Alnylam Pharmaceuticals listed its company stock on the Nasdaq exchange.
- Connect Biopharma Holdings Limited filed disclosures with the SEC and its stock is traded on the Nasdaq exchange.
- Pagaya technologies stock traded on the electronic exchange and required stock sales disclosures with the SEC on July 2, 2026.
- Odyssey Therapeutics, Inc. shares are being traded on the Nasdaq exchange.
- Corvus Pharmaceuticals began trading on the Nasdaq exchange on August 1, 2026.